Robin Swartz, Chief Operating Officer at Voyager Therapeutics, Inc. (VYGR), sold 3,966 shares at $7.45 ($30K) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market sale of $30k VYGR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |